AU2021103840A4 - Development of a Screening tool for Sleep Apnea for experts in clinical setups - Google Patents
Development of a Screening tool for Sleep Apnea for experts in clinical setups Download PDFInfo
- Publication number
- AU2021103840A4 AU2021103840A4 AU2021103840A AU2021103840A AU2021103840A4 AU 2021103840 A4 AU2021103840 A4 AU 2021103840A4 AU 2021103840 A AU2021103840 A AU 2021103840A AU 2021103840 A AU2021103840 A AU 2021103840A AU 2021103840 A4 AU2021103840 A4 AU 2021103840A4
- Authority
- AU
- Australia
- Prior art keywords
- sleep apnea
- breathing
- apnea
- development
- sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 201000002859 sleep apnea Diseases 0.000 title claims abstract description 19
- 238000011161 development Methods 0.000 title abstract description 4
- 238000012216 screening Methods 0.000 title abstract description 3
- 238000001514 detection method Methods 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 abstract description 23
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract description 15
- 208000001797 obstructive sleep apnea Diseases 0.000 abstract description 10
- 208000008784 apnea Diseases 0.000 abstract description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 208000035475 disorder Diseases 0.000 abstract description 4
- 206010021079 Hypopnoea Diseases 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 230000009467 reduction Effects 0.000 abstract description 2
- 208000003417 Central Sleep Apnea Diseases 0.000 abstract 2
- 208000020020 complex sleep apnea Diseases 0.000 abstract 2
- 201000006646 mixed sleep apnea Diseases 0.000 abstract 2
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 230000001684 chronic effect Effects 0.000 abstract 1
- 238000002565 electrocardiography Methods 0.000 description 16
- 238000004458 analytical method Methods 0.000 description 6
- 239000007943 implant Substances 0.000 description 5
- 238000000718 qrs complex Methods 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 230000000638 stimulation Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010041235 Snoring Diseases 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000006399 behavior Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000003434 inspiratory effect Effects 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 238000007781 pre-processing Methods 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010020591 Hypercapnia Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000006218 bradycardia Diseases 0.000 description 1
- 230000036471 bradycardia Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Landscapes
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
TITLE OF INVENTION: Development of a Screening tool for Sleep
Apnea for experts in clinical setups
FIELD OF INVENTION: COMPUTER SCIENCE
ABSTRACT
Sleep apnea is a type of breathing disorder caused by interruptions in breathing or shallow
breathing during night sleep. The disorder can occur in three different forms namely,
Obstructive Sleep apnea (OSA), Central Sleep apnea (CSA) and Mixed Sleep apnea (MSA)
among which OSA is the most prevalent. In all these three forms of sleep apnea, the interrupted
breathing activity leads to the problem of oxygen deficiency leading to the development of
chronic cardiac related ailments. Hence an earlier detection of sleep apnea can save patient
from life risk. The Invention discloses a low-power, high-performance algorithm for sleep
apnea detection based on ECG signal.
DRAWINGS
SHEET 1 OF 1
ECG Pre- QRS Feature Feature Classificat Apnea
signal processing -W Detectraction -k Reduction -o ion using - or
(BPF) using PT using PCA ANN Normal
Proposed PT-based method of sleep apnea detection
Description
DRAWINGS SHEET 1 OF 1
ECG Pre- QRS Feature Feature Classificat Apnea signal processing -W Detectraction -k Reduction -o ion using - or (BPF) using PT using PCA ANN Normal
Proposed PT-based method of sleep apnea detection
TITLE OF INVENTION: Development of a
Screening tool for Sleep Apnea for experts in
clinicalsetups
Polysomnography (PSG) is the gold standard test used for detection of sleep apnea disorder conducted in a sophisticated sleep lab facility under the supervision of a trained person. PSG is an overnight sleep test conducted on the patient .0 involving the monitoring of various physiological parameters tapped from the set of sensor electrodes put on patient's body. The test proves to be very cumbersome and expensive involving complex analysis.
The study is being carried out by several researchers for suggesting an alternative means of detecting sleep apnea that can
be used in a home environment with reduced number of physiological parameters tapped from the patient for analysis. Respiration function and Heart function re highly interdependent. The heart function can be captured using the Electrocardiography (ECG), a well established diagnostic modality available as a common health care facility. The respiration or the breathing information has representation in the normal ECG as its amplitude and frequency parameters in modulated form. During breathing disorder caused by sleep .5 apnea condition, ECG signal characteristics change and deviate from its normal characteristics. The medical experts observe such changes in ECG characteristics and infer about the sleep apnea conditions.
("US8037885B2"): A pharyngeal airway having a pharyngeal
wall of a patient at least partially surrounding and defining the
airway is treated by selecting an implant dimensioned so as to
be implanted at or beneath a mucosal layer of the pharyngeal
wall and extending transverse to said wall. The implant has
mechanical characteristics for the implant, at least in
combination with a fibrotic tissue response induced by the
implant, to stiffen said pharyngeal wall to resist radial
collapse. The implant is implanted into the pharyngeal wall
transverse to a longitudinal axis of the airway
("US10206571B2"): Apparatus, systems, and methods are
provided for treating obstructive sleep apnea. A CPAP system with an integrated oximeter sensor is disclosed wherein the sensor communicates with an oximeter processor that controls the blower. A nasal air flow sensor may also be incorporated that provides more data to the processor. A unique lightweight, flexible and stretchable hose for CPAP systems is also disclosed. The hose may have a magnetic connection with the blower.
("US7322356B2"): A method for treating a patient diagnosed
with obstructive sleep apnea includes identifying a patient as
having sleep apnea susceptible to a first positive airway
treatment which is at a first operating pressure level in excess
of that which is otherwise tolerable to the patient. The patient
is treated with an airway treatment selected to alter a portion
of an airway tissue of the patient. The patient is then treated
with a second positive airway pressure treatment at a second
pressure level, which is below the pressure threshold.
("CN107205693A"): Invention is related to a kind of
detection, the device for the generation assessed and terminate snoring, sleep apnea event and hypopnea event, it will be disorderly to reduce or eliminate anoxic, hypercapnia and heart and lung hemodynamics, and the mode in every morning to their crucial dormant datas of the user report of described device.
("CN107635615B"): Devices, systems, and methods for
treating obstructive sleep apnea are provided. A single valve
assembly removably located within the outer contour of the
nasal pillow mask uses positive airway pressure from a low
flow hose to automatically create a therapeutic-on-demand air
splint in the pharynx. During inhalation, the valve system of
the mask allows room air to be inhaled. During exhalation, the
other valve controls a therapeutic back pressure equal to the
prescribed pressure setting of the CPAP blower. The mask
may be worn with the CPAP blower off and provides a system
F5 to activate the CPAP blower only when needed.
("US10272226B2"): A device for treating a patient suffering
from obstructive sleep apnea or snoring can include an expiratory valve connected to a manifold. The expiratory valve can include a body portion including a feedback port configured to be connected to an air flow generator. The expiratory valve can include a plunger at least partially disposed in the body portion. The expiratory valve can include a pressurizing chamber positioned between an end of the plunger and an end of the expiratory valve. The pressurizing
|5 chamber can be configured to receive air from the air flow
generator through the feedback port.
("US5535739A"): In the treatment of
obstructive sleep apnea a method and apparatus are disclosed
for optimizing the controlled positive pressure to minimize the
flow of air from a flow generator while still ensuring that flow
limitation in the patient's airway does not occur. In particular,
the invention relates to a breathing device and method of use
to adjust a controlled positive pressure to the airway of a
patient by detecting flow limitation from analysis of an
inspiratory flow waveform. Once the presence of flow
limitation has been analyzed, the system determines an action to take for adjustment of the controlled positive pressure. The pressure setting is raised, lowered or maintained depending on whether flow limitation has been detected and on the previous actions taken by the system. The preferred breathing apparatus consists of a flow generator, a flow sensor, an analog to digital converter, a microprocessor, and a pressure controller, a patient supply hose, a nasal fitting, and, optionally, a pressure transducer. Using the method of the present invention, the microprocessor adjusts the air pressure in the patient supply hose when flow limitation is detected in the airway of the patient.
("US5803066A"): In the treatment of obstructive sleep apnea,
a method and apparatus are disclosed for detecting
obstructive apnea and optimizing the controlled positive
pressure to minimize the flow of air from a flow generator
while still ensuring that flow limitation in the patient's airway
does not occur. In particular, the invention relates to a
breathing device and method of use to adjust a controlled
1i nositive nressreto the airwav ofanatient hv detertino flow limitation from analysis of an inspiratory flow waveform.
Once the presence of flow limitation has been analyzed, the
system determines an action to take for adjustment of the
controlled positive pressure. The pressure setting is raised,
lowered or maintained depending on whether flow limitation
has been detected and on the previous actions taken by the
system. The preferred breathing apparatus consists of a flow
generator, a flow sensor, an analog to digital converter, a
microprocessor, and a pressure controller, a patient supply
hose, a nasal fitting, and, optionally, a pressure transducer.
Using the method of the present invention, the microprocessor
adjusts the air pressure in the patient supply hose when flow
limitation is detected in the airway of the patient
("US20160354603Al"): An upper airway stimulator for
treating obstructive sleep apnea is described. In some
embodiments, the upper airway stimulator monitors the phase
difference between ribcage expansion and abdomen
expansion to detect apneic events and stimulates to alleviate
those events. In some embodiments, the upper airway stimulator applies primary stimulation when an apneic event is not detected and secondary stimulation when an apneic event is detected. In some embodiments, the upper airway stimulator applies primary stimulation when the patient is not in an apneic position and secondary stimulation when the patient is in an apneic position.
("US7469697B2"): Methods and systems involve monitoring
one or more patient conditions using a monitoring device that
is fully or partially implantable. Feedback information is
developed based on the monitored conditions and is provided
to a device delivering therapy to treat sleep disordered
breathing. Components of the monitoring device are disposed
within an implantable housing that is separate from the
housing of the therapy device. The therapy device may
comprise a housing that is implantable or patient-external. The
feedback information may be used to adjust
the sleep disordered breathing therapy.
The plan of implementation of the detection of Sleep Apnea
can be realized using the various well established methods as
presented in Fig. 2. ECG being a noninvasive technique has a
large number of hidden parameters that help in detection of
the respiratory behavior, in turn the presence and absence of
Sleep Apnea. The first and the foremost step is to get the ECG
signal either using data acquisition hardware like analog front
end from the electrodes attached to human being or download
bio-signal recordings from healthy subjects as well those with
ailments. Next step is the preprocessing of ECG signal to
eliminate the undesired noise from it, so that the pure ECG
signal can be easily analyzed further for the accurate detection
of sleep apnea. Preprocessing involves cascaded stages of
filtering process involving a low pass filter (LPF) with cut off
150 Hz used to remove baseline wander noise, a high pass
filter with cutoff 0.05 Hz to remove motion artifacts and
finally a notch filter with cutoff 50 Hz to remove power line interference as shown. Based on the strategies that can be employed for ECG signal analysis, the important are the QRS complex detection, ECG feature Extraction, Heart
Rate Variability and ECG Derived Respiration (EDR) Signal
extraction. For each of the strategies followed, the important
signal processing methods used are the Pan Tompkins
algorithm, under time domain approach and
Fourier Transform, Wavelet Transform and Hilbert Transform
based techniques under frequency domain approach. The first
step common to all the methods is the QRS complex and
ventricular beat detection followed by morphological and
rhythm analysis. The parameters analyzed under each method
differ from each other.
7WI.nal for (Malmwbr krp pu '.'.deltion7
-- + 'i i t r p aw -' - , e $i ~uA .n,.
Trwkrs Ti 4If-enf
AIO hfl 1 Ldh $r JL i *"1&id 9A pit t *3
Surwy.f E basd OSAk dte~fcinhoed
ECG "d* Instrumentation L ow Pass Filterto
H High Pass Filter to Amplifier _moe_ base.line remove motion artifacts
& wader noise power line interference
Stepwise processes involved in data acquisition of`ECG signal
and also the range of RR intervals. Mean heart rate provides the information to distin guish the normal case with that of apnea condition. But if there are repeated episodes of bradycardia and tachycardia condition, then it is the presence of sleep apnea. Based on the number of episodes of apnea it can be decided as mild OSA, moderate OSA, severe OSA or simplynormalifthe heart rate is well withinthe ideal range ofheart beat between 60 to 70 bpm. The implementation of QRS complex detection, which can be imple mented either using Pan-Tompkins algorithm as shown or using wavelet trans formation technique as shown Amplitude and location of QRS complex is important to detect other parameters of ECG helpful in enhancing the accuracy of QRS detection. The collection of a set of parameters required to gather characteristics of ECG signal with respect to its respiration behavior.
Moving ECG SandPass Squaring window Sign al Filterfunction Integrator 4 Detected
Pan Tompkins algorithm for QRS complex detection
InputECG Signal Discrete Spline Moving Peak Detector it wavelet Interpolation Averaging Transform 4
|Threshold Stepwise process of discrete wavelet transform method
The above discussed procedures are implemented using LabVIEW2014 from TI providing the robust environment for data flow programming providing user friendly built-in functions
1 1 (i) 300 200 00A
10D 200 300 400 500 600
(ii) (iv)
. 200 30 .40 0 100 200 300 400 500 00
(iii) (v) O1S 03 - -. f - _
100 200 400 500 600 100 200 300 400 500 600
Stages of Pan-Tompkins algorithm: (i) a raw ECG signal X05, (ii) BPF output, (iii) differentiator output, (iv) squared output, and (v) output of MWI
Page 12 of 13
Claims (1)
- • The Invention discloses a low-power, high-performance algorithm for sleep apnea detection based onECG signal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN202141022036 | 2021-05-17 | ||
IN202141022036 | 2021-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021103840A4 true AU2021103840A4 (en) | 2022-04-14 |
Family
ID=81079604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021103840A Ceased AU2021103840A4 (en) | 2021-05-17 | 2021-07-03 | Development of a Screening tool for Sleep Apnea for experts in clinical setups |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021103840A4 (en) |
-
2021
- 2021-07-03 AU AU2021103840A patent/AU2021103840A4/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7913691B2 (en) | Session-by-session adjustments of a device for treating sleep disordered breathing | |
US10159421B2 (en) | Detection of periodic breathing | |
US5485851A (en) | Method and apparatus for arousal detection | |
US5549655A (en) | Method and apparatus for synchronized treatment of obstructive sleep apnea | |
EP0702978B1 (en) | Apparatus for treating obstructive sleep apnea | |
US5483969A (en) | Method and apparatus for providing a respiratory effort waveform for the treatment of obstructive sleep apnea | |
US5546952A (en) | Method and apparatus for detection of a respiratory waveform | |
US5540733A (en) | Method and apparatus for detecting and treating obstructive sleep apnea | |
KR100446133B1 (en) | Gas supply system | |
US7524292B2 (en) | Method and apparatus for detecting respiratory disturbances | |
US7160252B2 (en) | Method and apparatus for detecting respiratory disturbances | |
US20080257349A1 (en) | Multilevel Ventilator | |
WO2004062484A2 (en) | Method and device for detecting respiratory disturbances | |
EP1729636A1 (en) | Non-invasive method and device for detecting inspiratory effort | |
CN107126609A (en) | Malleation method of adjustment is exhaled/inhaled to the sleep-respiratory machine regulated and controled based on nervous activity | |
AU2021103840A4 (en) | Development of a Screening tool for Sleep Apnea for experts in clinical setups | |
AU2012216551B2 (en) | Session-By-Session Adjustment of a Device for Treating Sleep Disordered Breathing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) | ||
MK22 | Patent ceased section 143a(d), or expired - non payment of renewal fee or expiry |